Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: Reglan Injection (Metoclopramide Injection, USP), Equivalent to 5 Milligrams Base/Milliliter and Equivalent to 10 Milligrams Base/Milliliter

TitleDrug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: Reglan Injection (Metoclopramide Injection, USP), Equivalent to 5 Milligrams Base/Milliliter and Equivalent to 10 Milligrams Base/Milliliter
ToC Doc Reglan Injection (Metoclopramide Injection, USP), Equivalent to 5 Milligrams Base/Milliliter and Equivalent to 10 Milligrams Base/Milliliter
Docket Number2022-14929
Type Notice
Subject Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness:
Reglan Injection (Metoclopramide Injection, USP), Equivalent to 5 Milligrams Base/Milliliter and Equivalent to 10 Milligrams Base/Milliliter
Publication Date2022-07-13
Last Updated Date 2022-07-12 08:15:11 -0400
Last Public Inspection2022-07-12
Filed At2022-07-12T08:45:00.000-04:00
PDF 2022-14929_PI.pdf (50374 bytes)
Download TXT / HTML / JSON
Number of Pages 4
Filing Typeregular
AgenciesFood and Drug Administration

You can find the raw source document below...

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. OFR.report is not affiliated with the Office of the Federal Register or the US government in any way.

© OFR.report 2021